BIL | XBIL | BIL / XBIL | |
Gain YTD | 3.600 | 3.561 | 101% |
Net Assets | 34.4B | 604M | 5,695% |
Total Expense Ratio | N/A | N/A | - |
Turnover | N/A | 0.00 | - |
Yield | 5.09 | 5.14 | 99% |
Fund Existence | 17 years | 2 years | - |
BIL | XBIL | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | N/A | N/A |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | 3 days ago5% | N/A |
TrendWeek ODDS (%) | 3 days ago2% | 3 days ago1% |
TrendMonth ODDS (%) | 3 days ago2% | 3 days ago1% |
Advances ODDS (%) | 3 days ago1% | N/A |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 3 days ago3% | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ADOIX | 20.40 | 0.01 | +0.05% |
Axs Dynamic Opportunity I | |||
FFARX | 15.46 | N/A | N/A |
Franklin Global Allocation R | |||
TVRVX | 23.27 | N/A | N/A |
Third Avenue Real Estate Value Investor | |||
VEURX | 37.24 | -0.09 | -0.24% |
Vanguard European Stock Investor | |||
FTDZX | 153.28 | -1.05 | -0.68% |
Franklin Biotechnology Discovery Adv |